A bioprocess for the generation of pluripotent cell derived...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 5/08 (2006.01) C12N 5/00 (2006.01) C12N 5/06 (2006.01) C12Q 1/02 (2006.01)

Patent

CA 2351156

The present inventors identified aggregation of embryoid bodies (EBs) as the cause of the difficulty in generating large numbers of the embryonic stem cells (ES) cell-derived tissues. To counter this, the invention provides a novel bioprocess where aggregation of EBs is physically prevented, such as by an encapsulating matrix, Liquid Suspension Culture- encapsulated (LSCe). As a result, EBs can be cultured in high cell density, well-mixed systems. Well- mixed conditions facilitate measurement and control of the bulk media conditions and allow for the use of scalable bioreactor systems for clinical production of tissue. Therefore, LSCe enables generation of ES cell-derived tissue on a clinical scale. The invention is also applicable to other types of pluripotent cells

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A bioprocess for the generation of pluripotent cell derived... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A bioprocess for the generation of pluripotent cell derived..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A bioprocess for the generation of pluripotent cell derived... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1843733

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.